Illumina 测序组合试剂盒 EGMK81312

Illumina 测序组合试剂盒 EGMK81312

Illumina公司，致力于新一代测序和芯片技术的生产与开发，提供产品与应用资讯

Illumina公司创立于1998年4月，是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用，来改善人类健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

上海易汇生物科技有限公司于17年正式销售Illumina公司基因芯片、二代测序NGS测序仪及相关测序试剂盒等产品

咨询illumina MiSeq测序试剂盒等产品欢迎您致电 上海易汇生物科技有限公司：1850 1609 238张经理

Illumina 测序组合试剂盒 EGMK81312

产品编号： EGMK81312美  元  价： $1009.00会  员  价： 待定品       牌： Illumina产       地： 美国公       司： Illumina, Inc.产品分类： 分子类>二代测序>DNA文库制备试剂盒公司分类： Library Preparation Kits

"Product Highlights:

Unlock small samples (50–100 ng DNA input)

CpG, CHH, & CHG regions included for comprehensive, whole-genome results

Fast protocol – five-hour method

Capture full sample diversity

Sequence the entire sample–no loss of information

The process of bisulfite treatment denatures genomic DNA into single stranded DNA. TruSeq DNA Methylation converts single stranded DNA into an Illumina sequencing library. All ssDNA fragments are captured into an Illumina sequencing library, therefore eliminating the loss of diversity associated with other methods.

Supported analysis in the cloud

TruSeq DNA Methylation libraries can be aligned to the human genome and compared for differential methylation with Illumina BaseSpace Apps MethylSeq and MethylKit. These applications are fully supported and were developed specifically for TruSeq DNA Methylation library preparation.

Example data sets for TruSeq DNA Methylation libraries, also available in BaseSpace Sequence Hub Data Central (use the “Methyl Seq” category filter), demonstrate unparalleled quality and seamless analysis.

Deep coverage of critical genomic regions

Depth of coverage is enhanced in genomic areas with BIOLOGical utility. TruSeq DNA Methylation captures full sample diversity of critical areas, including:

Coding region start and end for exons from the canonical transcript of protein coding genes for genes known to be involved in cancer, taken from SOMA and CRUK panels (as well as literature-derived cancer genes)

Genes defined by the American College of Medical Genetics as being medically relevant (ACMG genes)

Exonic coding regions from Ensemble 70

List of 100 promoters defined by the Broad Institute as being of high interest and difficult to sequence"